chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was given Adacel (Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine ) for children greater than 7 yrs of age. Patient should have received Infanrix for children 7 and under
the evening after the vaccination felt generally poorly, then developed fever allegedly up to 104.0  associated with mental status change; felt better in AM, afebrile, and back to baseline state
Bell's palsy diagnosed on 11/13/13. Prescribed Prednisone, doxycycline and VALTREX. Lyme disease antibody ordered - negative. 11/25/13 - Follow-up appointment. 11/27/13 - Seen by ophthalmologist.
pt recv vax & pt devel a rash @ the inj site which covered an area the size of an egg;
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 05-SEP-2012, the patient was vaccinated with a dose of M-M-R II (injection, lot # reported as 1641Z, expiration date: 24-NOV-2012)(exact dose, dose number, therapy type and route of administration were not provided). On 29-SEP-2012 (less than 1 month apart), the patient was vaccinated with a dose of VARIVAX (lot # H011232, expiration date: 06-JUN-2014 (exact dose and route of administration were not provided). There was no adverse effect reported. Additional information has been requested.
Pt developed a rash on her left arm and hand. Dx'd with shingles.
I have a bump size of a baseball at the injection site went to doctor advised to apply ice since last Wed. November 3, 2021. It doesn't hurt just a bump coming out of my shoulder. My doctor has informed me it will subside not as of yet.
pt recv vax 13SEP96 & 15FEB98 pt exp a breakthrough of mild varicella w/approx 30 insects bite like lesions over face, trunk & oral mucosa;16FEB98 also exp mild fever of 100.5;
Chest; flu; back pain; chills; muscle ache; headache; little bit tired/ fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest), INFLUENZA (flu), BACK PAIN (back pain), CHILLS (chills) and MYALGIA (muscle ache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CHOLESTEROL for an unknown indication.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced CHEST DISCOMFORT (Chest), INFLUENZA (flu), BACK PAIN (back pain), CHILLS (chills), MYALGIA (muscle ache), HEADACHE (headache) and FATIGUE (little bit tired/ fatigue). At the time of the report, CHEST DISCOMFORT (Chest), INFLUENZA (flu), BACK PAIN (back pain), CHILLS (chills), MYALGIA (muscle ache), HEADACHE (headache) and FATIGUE (little bit tired/ fatigue) outcome was unknown.            Treatment information not provided. Other Concomitant medications included Anticancer medications.   This case was linked to MOD21-065571 (E2B Linked Report). This case was linked to MOD-2021-062208 (Patient Link).; Sender's Comments:  MOD21-065571:Link to Dose 2 with argus ID MOD-2021-062208
28FEB92 devel temp (temp no measured), n,v, red splotches in diaper area x 3 days; mom called MD who felt it was a rxn to DTP; MD ordered DT in future;
This case was reported by a healthcare professional and described the occurrence of decreased range of motion arm in a 64-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Historic vaccination included tetanus vaccine (non-gsk);non-GSK manufacturer;unknown;unknown given in 2008. Concurrent medications included PROTONIX. On 10 October 2012 at 11:00 the subject received unspecified dose of BOOSTRIX (.5 ml. intramuscular, left deltoid). On 11 October 2012, within 24 hours after vaccination with BOOSTRIX, the subject experienced injection site pain and extensive swelling of vaccinated limb. On an unspecified date the subject experienced decreased range of motion arm. The healthcare professional, who is also a nurse practitioner, reported that within 24 hours of BOOSTRIX administration the subject experienced swelling at the injection site that extended under the arm nearly to the elbow and also to the axilla and down to the "galline". The swelling resolved after three to four days. Since the swelling resolved, the subject has had decreased mobility/range of motion in her left arm and shoulder. The subject also experienced severe pain/aching at the injection site within 24 hours of BOOSTRIX administration which was still evident to the subject but had since improved. The subject had presented to the clinic to follow-up with the healthcare professional. At the time of reporting, the healthcare professional was considering a physical therapy referral for the subject. The healthcare professional considered the events were disabling. At the time of reporting the extensive swelling of vaccinated limb was resolved, injection site pain had improved and decreased range of motion arm was unresolved. The healthcare professional considered the events were probably related to vaccination with BOOSTRIX.
c/o stomachache 3 hrs p/immun; did not want to walk had bowel movement shortly a/; no previous problems;
Allergic type reaction Itching on face, scalp, arms, legs, torso Started approx. 50 hours after injection Treated with OTC Benadryl, 2 doses thus far Patient continued with milder itching and a tingling sensation, similar to a Niacin "flush" on the skin Continued condition remains after 72 hours after injection
She noticed swelling on the left side 24 hours later.; Headache; Lump the size of an orange under her right arm; This is a spontaneous report from a contactable consumer (patient).   A 62-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Solution for injection, Batch/Lot Number: EL3247 expiration date: unknown), via an unspecified route of administration, administered in Arm Right on 25Feb2021 14:00 (at the age of 62-year-old) as dose 2, single for covid-19 immunization. The patient did not have any medical history (was reported as none). There were no concomitant medications. History of previous immunizations was not provided. There were no additional vaccines administered on same date of Pfizer suspect. Prior vaccinations within 4 weeks or any adverse events following prior vaccinations. After second dose of COVID vaccine, patient had a giant lump the size of an orange under her arm. It went down from there and felt like when her milk came in after having a baby, but not as bad. Her breast hurt and she could not use the injection arm. She had the second COVID Vaccine on Thurs-day. She had some soreness on Friday (26Feb2021), but thought it was no big deal. By Friday evening, it was not just a little sore. On Saturday (27Feb2021), she looked at it and noticed the lump the size of an orange. The swelling was down to the size of a golf ball. She also had a headache on an unspecified date. Patient was asking if the agent thought she needed to see a doctor. Patient was assuming the lump would eventually go away. It was clarified the lump and swelling began in the right arm. The swelling did spread to the left side, but not nearly as bad. She noticed swelling on the left side 24 hours later. The outcome of outcome of headache was reported as resolving, and outcome of lump the size of an orange under her right arm and swelling was unknown.  No follow-up attempts were possible. No further information was expected.
Extreme pain in entire arm of administration. Pt finally got some movement back in it on 12/15. Still no usage of arm. Pt never had persistent but debilitating pain over every aspect of arm that rendered it useless.
Pt presented with maculopapular rash below left shoulder blade and above left breast; rash appeared on 07/15/10. Pt denies fever, myalgias, headache or loss of appetite. Pt was referred to her primary care physician 07/15/10 and was diagnosed with moderate outbreak of shingles. No treatment was prescribed.
Severe emesis (x7)  24 - 30 hours following  DPT.   Unclear if could have been unrelated event such as gastroenteritis.  Partner not ill.  Patient fully recovered.
Patient with history of asthma and diabetes. She presented to the ED  the night of 1/9/23 with weakness, confusion, productive cough, and shortness of breath. She has had symptoms for the past few days, however they have been progressively worsening. The morning of 1/9, her husband noticed she appeared significantly disoriented and confused. A COVID PCR test done in the ED resulted positive.  Patient was admitted 1/10 - 1/12 for COVID-19 and UTI. Patient has received the primary COVID vaccine series.
This is a spontaneous report from a contactable pharmacist. A male patient of an unspecified age received PREVNAR 13 (Lot number: S51635, Expiration date: 30Oct2018), via an unspecified route of administration on the left arm in 2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient received a dose of the product about one week ago on an unspecified date in 2018, and his left arm was still swollen at the site and his left arm was itchy.
Had reaction to MMR, Varicella and PCV-13 immediate redness and hives around injection site of all vaccines. Given Benadryl and observed for 20m. Redness decrease and hives gone after 20m.
No patients experienced symptoms.; Impropertly stored doses of varivax were administered; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions and concomitant medications were not reported.  On 01-JUN-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck)(VARIVAX), subcutaneous (dose and frequency were not provided; Lot number reported as S032357 has been verified to be valid; expiration date reported and validated as 14-OCT-2021) for prophylaxis. The vaccine was reconstituted using a properly stored sterile diluent (MERCK STERILE DILUENT).  The vaccine underwent a temperature excursion of 17.2 Fahrenheit for a period of 14 hours and 2 minutes. The vaccine did not underwent a previous temperature excursion. The excursion was called by a digital data logger. The nurse reported that the patient did not experience any symptom.  This is one of several reports received from the same source.; Sender's Comments:  US-009507513-2006USA001641: US-009507513-2006USA001815: US-009507513-2006USA001816: US-009507513-2006USA001817: US-009507513-2006USA001818:
Started bleeding vaginally 6 days after receiving the booster dose of pfizer vaccine. Received vaccine on 2/27/22 and began bleeding 3/5/22. This time frame is about two weeks earlier than my expected menstrual cycle which is usually normal and on schedule. The bleeding stopped on 3/12/22.
Within 5 minutes of receiving vaccination, the patient became pale, listless, and legs looked slightly swollen. Symptoms resolved in 15-30 minutes. No further problems were noted.
Child developed hive type rash approx 1 hour after receiving vaccines, both legs and right hand, referred to local ER given BENADRYL and oral steroid. Rash continued x 11 days. Referred to allergist.
Bleeding from nose.  This also happened after the first dose within a few days as well.  It went away on its on its two days after it started with the first dose.
Patient received first dose of covid vaccine on 1/22/2021.  Patient had no immediate reaction.  Patient presented  to the Emergency Department on 1/26/2021 c/o shortness of breath and chest pain. ECG showed a ST elevation myocardial infarction.  Patient was treated and transferred to a cath lab where he died.  Patient had significant coronary artery disease.
became faint;eyes rolled back, jerking movements, fainted became pale;no breakfast & was very nervous;VS 10AM BP 100/50, 56, 16;10:15 100/50, 72, 20;
pt revcd vax 14SEP92 began w/hives & rash 15SEP92 w/itching & redness; called MD 16SEP92 advised DPH-redness & rash unresolved as of 22SEP92; seen by MD 21SEP92 was given Depo-Medrol;
Breakthrough case admission after 4 vaccines Modern 3/28/21 lot# 018B21A;  Moderna 4/25/21 lot# 025B21A;  Moderna 11/20/21 lot# 013F21A;  Moderna 7/8/22 lot# 004M21A
This case was reported by a consumer via call center representative and described  the occurrence of febrile seizure in a adolescent male patient who received Flu Seasonal TIV Dresden. Concurrent medical conditions included seizure. On an unknown date, the patient received influenza vaccine. On an unknown date, 1 day after receiving Influenza vaccine, the patient experienced febrile seizure (serious criteria GSK medically significant). On an unknown date, the outcome of the febrile seizure was recovered/resolved. The reporter considered the febrile seizure to be probably related to influenza vaccine. Additional details were reported as follows: the case was reported by the patient's parent. This case was previously reported to physician. the age at vaccination was not reported. The patient has denied permission to contact their physician. In 2015, the patient experienced fever and increased incidence of seizures after receiving flu vaccine.
Pt recieved vaccination and at post vaccination waiting station, pt felt nauseated and a little dizzy. I raised patient's feet, gave him some water and placed a cold ice pack on his neck. He then threw up multiple times.  After about 15 minutes, pt felt a lot better and left with mom
One to two hours after injection had a single large hive right arm. Redness measured 60 mm L by 30 mm W and induration at 10 mm L by 5 mm W. Stable vital signs. Released from office 20-30 mins after.
pt recvd vax 15JUL94 & devel lethargy, irritability & t99 @ 4PM; t101 @ 12AM 16JUL94 then 104 230AM 16JUL94; pt given cool bath & cont APAP & temp dec to nl;
12 hours post each vaccination, i have had body aches, especially in my hips, chills, light headedness, and a rash all over my torso.   I have also passed in an out of consciousness when while I had the chills and was light headed.   I vomited for the first 2 vaccinations, but not the last one.  Within 24-36 hours of the vaccinations I have felt better.
I received my Covid vaccine on 12/13/2021 at pharmacy. I felt very tired after and went home and slept. The next day when I woke up around noon, I had a severe headache. This headache continues nonstop since then. Before this, I have never had one headache. This vaccine has ruined my life.
Left arm was pink and warm from top of arm to elbow. It had improved since yesterday according to patient.
Hives on arms.  Advised mother to give benadryl and call if no better.  No shortness of breath, no vomiting.  Hives went away after one dose of benadryl.
Itchy mouth and lips; Itchy mouth and lips; Itchiness; Sore arm; Headache; sinus pain for one day; Enlarged lymph nodes under arm, right breast, under neck and down sides of neck; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0180) via an unspecified route of administration in the right arm on 01Aug2021 at 13:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and blood pressure high and unspecified allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had known (unspecified) allergies to medications, food or other products. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Aug2021 at 13:30, the patient experienced itchy mouth and lips, itchiness, sore arm, headache, sinus pain for one day, enlarged lymph nodes under arm, right breast, under neck and down sides of neck. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sinus pain for one day was recovered on unknown date in Aug2021 and of the itchy mouth and lips, itchiness, sore arm, headache and enlarged lymph nodes under arm, right breast, under neck and down sides of neck was not recovered at the time of this report.
Lethargic ~5 hours post vaccination; Chills throughout the night; 18 Hours post vaccination consistent headache; This is a spontaneous report from a Non-contactable consumer (patient).   A 28-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number=EL3247) dose 2, via an unspecified route of administration in Left arm on 18Feb2021 at 13:45PM (at the age of 28- year-old) as 2nd dose, single for covid-19 immunisation. Medical history included Chronic knee pain. No known allergies. The patient received other medications in two weeks: Spironolactone 100 mg, Clindamycin topical lotion. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1, via an unspecified route of administration, administered in Left arm on 28Jan2021 02:00 PM (Batch/Lot number=EL3247) as 1st dose, single for covid-19 immunisation. The patient had no COVID prior vaccination. The patient did not receive any other vaccine in four weeks. The patient was not tested COVID-19 post vaccination. On 18Feb2021 at 20:15 PM, the patient experienced lethargic 5 hours post vaccination, chills throughout the night, 18 hours post vaccination consistent headache. The patient did not receive any treatment for the events. The outcome of the events was recovered.  No follow up attempts are possible. information about lot/batch number cannot be obtained.
This spontaneous report was received from a male nurse of an unknown age, who was also the patient referring to himself. The patient's medical history was not reported. The patient's concurrent conditions included allergy to sulfa, Cipro and cephalexin (KEFLEX). On an unknown date, the patient was vaccinated with the 3rd dose of M-M-R II intravenously (lot # and expiry date were not reported). On an unknown date, on 2011, the patient he was entering nursing school and had a titer drawn for immunity to measles, mumps, rubella even having been vaccinated at an unspecified earlier time in his life. The patient stated that one or more titers showed "low" so he required a third dose of M-M-R II (viral titre decreased). On an unknown date, the patient stated that when the third dose of M-M-R II was administered, it was administered "intravenously" (incorrect route of drug administration) and his heart rate "shot up". At that time, he was treated for elevated heart rate (diagnosed at the time as SVT: supraventricular tachycardia) by an unspecified physician (supraventricular tachycardia). The patient stated that he "had had this heart rate problem ever since, controlled with generic Metoprolol." The outcome of supraventricular tachycardia was reported as not recovered/not resolved. The outcome of incorrect route of drug administration and viral titre decreased was unknown. No causal relationship assessment between the vaccine and the supraventricular tachycardia was provided by the reporter. Additional information has been requested.; Sender's Comments: US-009507513-1708USA002130:
I have been getting smell like cigarette smoking which is pretty intense; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 23Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1), for COVID-19 Immunization. The following information was reported: PAROSMIA (non-serious) with onset Apr2021, outcome "not recovered", described as "I have been getting smell like cigarette smoking which is pretty intense".  Additional information: It was reported that, patient had taken both the Pfizer Covid vaccine and patient took second shot on 23Apr and after that been getting the smell like cigarette smoking smell which was pretty intense and patient was wondering, what's the reason behind it.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Can't stand up; Can't taste anything; Tremendous headaches; This is a spontaneous report from a Non contactable consumer (Patient). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown), via unspecified route of administration, on 18Jun2021, as 1st dose, single for COVID-19 Immunisation. Medical history and concomitant medications were not reported. On an unknown date in Jun2021, the patient experienced tremendous headaches, can't stand up, and can't taste anything. The reporter reported events as non serious. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
can not move; Back problems; not sleeping; Breathing problems.; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced cannot move, back problems, not sleeping, breathing problems. The outcomes of events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
"Pfizer-BioNTech Covid 19 vaccine EUA": About 24 hours after my second shot, I felt strong nausea, losing control of the environment, feeling very unwell, weak, blood pressure must have dropped, my vision had darkened, I was about to collapse on the floor had I not reached my bed quickly. Couple of minutes later I had the urge to vomit but nothing came out, and then I had a normal bowl movement. After all that, I felt like the pressure had been released, took 1 tylenol, and went back to bed to rest. It's been 4 days now since the fainting symptoms, and I've been fine so far. The scary part was really the fainting symptoms, I wasn't expecting that.